Literature DB >> 19367373

[Sarcoidosis].

A Prasse1, J Müller-Quernheim.   

Abstract

Sarcoidosis is the most frequent interstitial lung disease of unknown origin affecting patients of younger age in many cases. In Germany its incidence is higher than that of tuberculosis. Diagnosis is made by demonstration of epitheloid, non-necrotizing granuloma in pulmonary parenchyma and by exclusion of other granulomatous disorders such as mycobacteriosis, berylliosis, or hypersensitivity pneumonitis. Its etiology is still elusive and since it is a systemic disease any organ can be involved. The lung is most frequently involved and, therefore, diagnosis can easily be made by bronchoscopy with transbronchial biopsy and bronchoalveolar lavage. Frequently a favorable spontaneous course takes place but in about one third of the cases a chronic course of disease is seen which requires systemic treatment with prednisolone. In progressive disease despite prednisolone treatment the combination with azathioprine or methotrexate might be helpful.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19367373     DOI: 10.1007/s00108-009-2382-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  19 in total

1.  A case control etiologic study of sarcoidosis: environmental and occupational risk factors.

Authors:  Lee S Newman; Cecile S Rose; Eddy A Bresnitz; Milton D Rossman; Juliana Barnard; Margaret Frederick; Michael L Terrin; Steven E Weinberger; David R Moller; Geoffrey McLennan; Gary Hunninghake; Louis DePalo; Robert P Baughman; Michael C Iannuzzi; Marc A Judson; Genell L Knatterud; Bruce W Thompson; Alvin S Teirstein; Henry Yeager; Carol J Johns; David L Rabin; Benjamin A Rybicki; Reuben Cherniack
Journal:  Am J Respir Crit Care Med       Date:  2004-09-03       Impact factor: 21.405

Review 2.  Sarcoidosis.

Authors:  Michael C Iannuzzi; Benjamin A Rybicki; Alvin S Teirstein
Journal:  N Engl J Med       Date:  2007-11-22       Impact factor: 91.245

Review 3.  Treatment of sarcoidosis.

Authors:  Robert P Baughman; Ulrich Costabel; Ronald M du Bois
Journal:  Clin Chest Med       Date:  2008-09       Impact factor: 2.878

Review 4.  Sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower; Roland M du Bois
Journal:  Lancet       Date:  2003-03-29       Impact factor: 79.321

5.  Cardiac involvement in sarcoidosis.

Authors:  Jane C Deng; Robert P Baughman; Joseph P Lynch
Journal:  Semin Respir Crit Care Med       Date:  2002-12       Impact factor: 3.119

6.  Therapy for extrapulmonary sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower
Journal:  Semin Respir Crit Care Med       Date:  2002-12       Impact factor: 3.119

7.  Computed tomographic scanning in sarcoidosis.

Authors:  Joseph P Lynch
Journal:  Semin Respir Crit Care Med       Date:  2003-08       Impact factor: 3.119

Review 8.  Epidemiology of sarcoidosis: recent advances and future prospects.

Authors:  Benjamin A Rybicki; Michael C Iannuzzi
Journal:  Semin Respir Crit Care Med       Date:  2007-02       Impact factor: 3.119

9.  Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.

Authors:  Robert P Baughman; Marjolein Drent; Mani Kavuru; Marc A Judson; Ulrich Costabel; Roland du Bois; Carlo Albera; Martin Brutsche; Gerald Davis; James F Donohue; Joachim Müller-Quernheim; Rozsa Schlenker-Herceg; Susan Flavin; Kim Hung Lo; Barry Oemar; Elliot S Barnathan
Journal:  Am J Respir Crit Care Med       Date:  2006-07-13       Impact factor: 21.405

10.  Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.

Authors:  Alvin S Teirstein; Josef Machac; Orlandino Almeida; Ping Lu; Maria L Padilla; Michael C Iannuzzi
Journal:  Chest       Date:  2007-10-09       Impact factor: 9.410

View more
  6 in total

1.  [B symptoms, lymphadenopathy and signs of systemic disease in a 21-year-old female].

Authors:  J Mühlhausen; G A Müller; H Eiffert; G Wulf; K Holke; M Koziolek
Journal:  Internist (Berl)       Date:  2012-07       Impact factor: 0.743

2.  [A rare tumor-like lesion of the pancreatic head with bile duct obstruction].

Authors:  T Beridze; M Tsintsadze; U Völker; G Klöppel; K Heiler; R J Schauer
Journal:  Chirurg       Date:  2011-08       Impact factor: 0.955

3.  [Granulomatous lung and systemic diseases].

Authors:  A Prasse; G Kayser; J Müller-Quernheim
Journal:  Internist (Berl)       Date:  2013-04       Impact factor: 0.743

Review 4.  [Non-infectious granulomatous inflammation: Focus on the lungs and skin].

Authors:  K Holl-Ulrich; C Rose
Journal:  Pathologe       Date:  2016-03       Impact factor: 1.011

Review 5.  [Neurosarcoidosis].

Authors:  W Reith; S Roumia; C Popp
Journal:  Radiologe       Date:  2016-10       Impact factor: 0.635

Review 6.  [Clinical pathology of granulomatous inflammation : With special emphasis on the lungs and central nervous system].

Authors:  C Tóth
Journal:  Radiologe       Date:  2016-10       Impact factor: 0.635

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.